Oct 2026· European Journal of Public Health· Vol 36· 0 citations
TL;DR
The SRIA outlines the key areas that must be addressed in order to fully realise the potential of personalised prevention within European health systems and identifies a comprehensive set of 56 goals and 66 actions aimed at strengthening evidence generation, interoperability, real-world implementation and capacity building.
Abstract
Abstract Background Despite the scientific advances in omics technologies, the translation of precision approaches into population-level prevention strategies remains limited. The EU-funded project “A PeRsOnalised Prevention roadmap for the future HEalThcare in Europe” (PROPHET) promotes a comprehensive vision of personalised prevention (PP) that integrates biomedical, behavioural and social determinants of health. Methods Based on literature mapping, consortium input and large stakeholder engagement, the SRIA identified key challenges for the implementation of PP, while the accompanying Roadmap translated these challenges into concrete actions by outlining goals, priority actions, timelines, expected outcomes and output indicators, responsible entities, funding sources, and synergies with other EU initiatives. Results Ten challenges for implementing PP have been identified: Scope of health promotion and prevention; Continuous evidence synthesis for PP; Implementation of the PROPHET framework; Data collection, integration and infrastructure; Community engagement and trust; Involvement of health professionals and policy makers; Regulatory frameworks and collaboration with the private sector; Access, equity and coverage; Ethical, legal and social issues (ELSI); Behaviour change. Across the ten challenges, the roadmap identifies a comprehensive set of 56 goals and 66 actions aimed at strengthening evidence generation, interoperability, real-world implementation and capacity building. The anticipated implementation timeline spans the next five years, with the aim of generating long-term impact on European health systems. For most of the actions, the principal entities responsible for supporting implementation include the European Commission (DG SANTE, DG RTD), National Ministries of Health and related agencies, and the research community. Conclusions The SRIA and Roadmap highlight both the opportunities and the potential barriers that may emerge during PP implementation. Key messages • The SRIA outlines the key areas that must be addressed in order to fully realise the potential of PP within European health systems. • Implementation of PP requires coordinated investment and collaboration among European institutions, national authorities and the research community.
Abstract Background Personalised prevention (PP) aims to target interventions based on the combination of biological, lifestyle and socioeconomic factors, but requires structured approaches integrating organisational, equity, societal dimensions. The EU-funded project PeRsOnalized Prevention roadmap for the future HEal...
E. Giacobini, S. Farina, A. Sabatelli et al.· European Journal of Public H...· 0 citations
The framework promotes risk stratification integrating omics, clinical history, environmental exposures, and behavior, alongside continuous monitoring enabled by digital tools and biomarkers to anticipate health decline, and social determinants are embedded to ensure feasibility and equity.
S. Boccia, S. Farina, E. Giacobini et al.· European Journal of Public H...· 0 citations
Abstract Background Primary cancer prevention is widely acknowledged as a shared responsibility among citizens, healthcare practitioners, and policymakers. In line with the objectives of EU Cancer Mission, the 4P-CAN project aims to reduce cancer risk factors, improve prevention, and address inequalities. Objectives To...
M. Geantă, C. Cioroboiu, M. Ghiță· European Journal of Public H...· 0 citations
Abstract Background Effective cancer prevention necessitates programmes that address modifiable risk factors. As part of PIECES a methodological implementation framework (PCP-IT) tailored to cancer is created, evaluated, and distributed. Objectives To co-develop and implement an integrated PCP Implementation Toolkit th...
C. Martínez, S. Semple, R. O'Donnell et al.· European Journal of Public H...· 0 citations
Abstract JA PreventNCD is a four-year EU Joint Action, one of the largest ones in public health, involving 25 countries, aiming to reduce the burden of cancer and other non-communicable diseases (NCDs) by addressing common risk factors at both personal and societal levels. It seeks to strengthen prevention policies, im...
H. Snorradóttir, S. Karlsdóttir, F. Gudlaugsson· European Journal of Public H...· 0 citations
Abstract Background Occupational settings represent an underutilised entry point for cancer prevention. Workers and their families are exposed to modifiable cancer risk factors - including infectious agents - yet are insufficiently reached by conventional prevention. CPW assesses the efficacy of incorporating primary p...
P. Boffetta, M. Kostrzewa, Á. Honrado et al.· European Journal of Public H...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.